No internet connection — showing the saved version of the page.

Merck KGaA

DEEUR
← to the screener

Merck KGaA (LSE:0O14) — Drug Manufacturers - Specialty & Generic. Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.

⚠ Don't mix them up: there is another company with the same or a very similar name. It is a separate record — check the ticker, exchange and registration number.
  • Merck KGaA ADR — 1MRKX · MI US CIK 310158 · LEI 4YV9Y5M8S0BRK1RP0397 · ISIN US58933Y1055

About the company

Website
merckgroup.com
Sector
Healthcare · Drug Manufacturers - Specialty & Generic
Headquarters
Darmstadt, Germany
CEO
Belén Garijo
Employees
60 348
Founded
1668
Listed since
17.07.2007 (LSE:0O14)
Shares outstanding
129.24 M
Free float
128.87 M
Market cap
59.93 B EUR
Insiders
0%
Institutions
57.83%
Description

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Exchanges and tickers

ExchangeTickerCurrencyPriceType
XETRA XetraMRK primaryEUR138.1 +0.51%common stock
LSE London Stock Exchange0O14 IOBEUR137.725 +1.64%common stock
US USA StocksMKGAF OTCUSD160.752 +4.22%common stock

Price for 3 months

up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

Last 12 months, XETRA:MRK: 2.2 EUR (1 paym.)

Merck KGaA (MRK) pays dividends once a year. Over the last 12 months, 2.2 EUR per share was paid (payments: 1). That is about 1.59% of the current share price. Based on payment history, the next ex-dividend date is expected around 26.04.2027.

Ex-datePaymentAmount%TypeTicker
2026-04-272026-04-292.2000 EUR1.6/1.6 %annualXETRA:MRK
2025-04-282025-04-302.2000 EUR1.6/1.6 %annualXETRA:MRK
2024-04-29—2.2000 EUR1.6/1.6 %annualXETRA:MRK
2023-05-02—2.2000 EUR1.6/1.6 %annualXETRA:MRK
2022-04-25—1.8500 EUR1.3/1.3 %annualXETRA:MRK

News this week

No news from the company's website yet.

advertisement

Top holders

HolderStakeSharesReport date
First Eagle Funds-First…4.7%6.07 M2026-07-31
MFS Series Trust XVII-MF…1.78%2.3 M2026-06-30
First Eagle Funds-First…1.59%2.06 M2026-07-31
VANGUARD STAR FUNDS-Vang…1.48%1.91 M2026-07-31
Bridge Builder Trust-Bri…1.36%1.76 M2026-06-30
VANGUARD TAX-MANAGED FUN…0.98%1.27 M2026-06-30
MFS SERIES TRUST I-MFS R…0.76%988 0282026-05-31
iShares Trust-iShares Co…0.75%964 9962026-08-31
MFS SERIES TRUST X-MFS I…0.73%947 8552026-05-31
BNY Mellon Strategic Fun…0.41%532 2002026-05-31
Generali Investments Cee…0%6 2362026-06-30
Pacer Advisors, Inc.0%4 9262026-06-30
Reik & Co., Llc0%4 0002026-06-30
Gamma Investing LLC0%342026-09-30